# Varenicline In-Patient Study

> **NCT01413516** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 17 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **BEHAVIORAL:** Smoking cessation counseling
- **DRUG:** Placebo
- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01413516
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01413516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01413516, "Varenicline In-Patient Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01413516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*